{
  "id": 20908840,
  "title": "CytoSorbents Announces $6.25 Mln Stock Financing; Agrees With Avenue Capital On A Debt Amendment",
  "url": "https://urgent.news/2026/11/20/cytosorbents-announces-6-25-mln-stock-financing-agrees-with-avenue",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-20T13:54:51.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/cytosorbents-announces-625-mln-stock-financing-agrees-avenue-capital-debt-amendment"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - CytoSorbents Corp. (CTSO), a medical device company specializing in blood purification technologies, Friday announced a $6.25 million stock financing and an agreement with Avenue Capital Group to reduce debt and extend its loan maturity.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}